RT Journal Article T1 Development and validation of the VISAGE AmpliSeq basic tool to predict appearance and ancestry from DNA A1 Xavier, Catarina A1 Puente Vila, María del Carmen de la A1 Mosquera Miguel, Ana A1 Freire Aradas, Ana María A1 Kalamara, Vivian A1 Vidaki, Athina A1 Gross, Theresa E. A1 Revoir, Andrew A1 Pośpiech, Ewelina A1 Kartasińska, Ewa A1 Spólnicka, Magdalena A1 Branicki, Wojciech A1 Ames, Carole E. A1 Schneider, Peter M. A1 Hohoff, Carsten A1 Kayser, Manfred A1 Phillips, Christopher Paul A1 Parson, Walther A1 The VISAGE Consortium, K1 Forensic DNA phenotyping K1 Appearance and bio-geographical ancestry prediction K1 MPS Ion S5 K1 AmpliSeq K1 SNP multiplex AB Forensic DNA phenotyping is gaining interest as the number of applications increases within the forensic genetics community. The possibility of providing investigative leads in addition to conventional DNA profiling for human identification provides new insights into otherwise “cold” police investigations. The ability of reporting on the bio-geographical ancestry (BGA), appearance characteristics and age based on DNA obtained from a crime scene sample of an unknown donor makes the exploration of such markers and the development of new methods meaningful for criminal investigations. The VISible Attributes through GEnomics (VISAGE) Consortium aims to disseminate and broaden the use of predictive markers and develop fully optimized and validated prototypes for forensic casework implementation. Here, the first VISAGE appearance and ancestry tool development, performance and validation is reported. A total of 153 SNPs (96.84 % assay conversion rate) were successfully incorporated into a single multiplex reaction using the AmpliSeq™ design pipeline, and applied for massively parallel sequencing with the Ion S5 platform. A collaborative effort involving six VISAGE laboratory partners was devised to perform all validation tests. An extensive validation plan was carefully organized to explore the assay’s overall performance with optimum and low-input samples, as well as with challenging and casework mock samples. In addition, forensic validation studies such as concordance and mixture tests recurring to the Coriell sample set with known genotypes were performed. Finally, inhibitor tolerance and specificity were also evaluated. Results showed a robust, highly sensitive assay with good overall concordance between laboratories PB Elsevier SN 1872-4973 YR 2020 FD 2020 LK http://hdl.handle.net/10347/24243 UL http://hdl.handle.net/10347/24243 LA eng NO Forensic Science International: Genetics, Volume 48, September 2020, 102336 NO The study received support from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 740580 within the framework of the VISible Attributes through GEnomics (VISAGE) Project and Consortium. MdlP is supported by a postdoctoral fellowship awarded by the Consellería de Cultura, Educación e Ordenación Universitaria and the Consellería de Economía, Emprego e Industria from Xunta de Galicia (Modalidade A, ED481B 2017/088). AFA is supported by a post-doctorate grant funded by the Consellería de Cultura, Educación e Ordenación Universitaria e da Consellería de Economía, Emprego e Industria from Xunta de Galicia, Spain (Modalidade B, ED481B 2018/010). The 1000 Genomes high coverage sequence data were generated at the New York Genome Center with funds provided by NHGRI Grant 3UM1HG008901-03S1 DS Minerva RD 24 abr 2026